Turn Therapeutics Inc. Common Stock (TTRX) — Net Asset Momentum
Turn Therapeutics Inc. Common Stock (TTRX) recorded a net asset momentum of 2741.4% as of December 2025, with net assets of $4.69 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Turn Therapeutics Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Turn Therapeutics Inc. Common Stock Net Asset Momentum (2023–2025)
This chart tracks Turn Therapeutics Inc. Common Stock's year-over-year net asset growth across 3 annual reporting periods from 2023 to 2025. The most recent momentum reading is +2741.4%, with net assets of $4.69 Million USD as of December 2025. See how financially flexible is Turn Therapeutics Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
Annual Net Asset History for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below shows the complete annual net asset history for Turn Therapeutics Inc. Common Stock from 2023 to 2025, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Turn Therapeutics Inc. Common Stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $4.69 Million | $12.16 Million | $7.48 Million | ▲ +2741.4% |
| 2024 | $-177.43K | $2.05 Million | $2.23 Million | ▼ -306.9% |
| 2023 | $85.77K | $2.01 Million | $1.93 Million | — |